Monday, September 22, 2025 6:04:10 PM
AllSheWrote,
Linda knew about big pharma influence on FDA and she knew about the subjective nature of BLA decision making. Over the years this message board has discussed people that have been compromised and issues that have played out at FDA that required some changes in this regard. The SEC and FINRA are others that have been chummy with Wall Street powerhouses. So there is a lawsuit against the Wall Street perps and avoidance of FDA until they can no longer be leveraged against NWBO under the cover of subjective decision making at which time Edens will also be ready for a major scale ramp up. More time but also more certainty and the little guys need certainty and the ability to overcome the time issue in order to succeed. Linda has brought the company through the time issue. Now the greater certainty strategy of channeling through less compromised waters plays out even though taking more time than hoped for by most of not all longs; ). Best wishes.
Linda knew about big pharma influence on FDA and she knew about the subjective nature of BLA decision making. Over the years this message board has discussed people that have been compromised and issues that have played out at FDA that required some changes in this regard. The SEC and FINRA are others that have been chummy with Wall Street powerhouses. So there is a lawsuit against the Wall Street perps and avoidance of FDA until they can no longer be leveraged against NWBO under the cover of subjective decision making at which time Edens will also be ready for a major scale ramp up. More time but also more certainty and the little guys need certainty and the ability to overcome the time issue in order to succeed. Linda has brought the company through the time issue. Now the greater certainty strategy of channeling through less compromised waters plays out even though taking more time than hoped for by most of not all longs; ). Best wishes.
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
